In Hampshire and the Isle of Wight and across the NHS there is different help available depending on the level of support you require to help you in your weight loss journey.

Currently across NHS Hampshire and Isle of Wight, which includes Portsmouth and Southampton, neither semaglutide (Wegovy) or tirzepatide (Mounjaro) injections are available for managing weight loss and obesity.

From 23 June 2025, people living with obesity will be able to begin accessing tirzepatide (Mounjaro®) for weight loss purposes in primary care settings. This does not mean prescriptions will be provided immediately. It means primary care settings can begin discussions with patients about whether tirzepatide is the right option to improve their health through weight loss.

Please click on the image below to open the NHS Hampshire & Isle of Wight Website for more information.